Showing results (91-100 of 154) with videos related to
Sort By:
Pageof 16
Molecular Biology of the Cell|March 30, 2022
Cell Painting predicts impact of lung cancer variantsJuan C Caicedo, John Arevalo, Federica Piccioni, et al.Oncogene|June 10, 2014
PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signalingS E Moody, A C Schinzel, S Singh, et al.Cell Reports. Medicine|November 1, 2021
Weekly SARS-CoV-2 screening of asymptomatic kindergarten to grade 12 students and staff helps inform strategies for safer in-person learningShira Doron, Robin R Ingalls, Anne Beauchamp, et al.Methods (San Diego, Calif.)|December 3, 2014
Building the Connectivity Map of epigenetics: chromatin profiling by quantitative targeted mass spectrometryAmanda L Creech, Jordan E Taylor, Verena K Maier, et al.Science Signaling|May 17, 2012
MicroSCALE screening reveals genetic modifiers of therapeutic response in melanomaKris C Wood, David J Konieczkowski, Cory M Johannessen, et al.Genome Biology|August 23, 2023
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethalJ Michael Krill-Burger, Joshua M Dempster, Ashir A Borah, et al.Oncogene|November 23, 2011
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingY Shrestha, E J Schafer, J S Boehm, et al.Cell Systems|September 30, 2016
Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active CancersJoseph Rosenbluh, Johnathan Mercer, Yashaswi Shrestha, et al.Plos One|February 4, 2010
CK1epsilon is required for breast cancers dependent on beta-catenin activitySo Young Kim, Ian F Dunn, Ron Firestein, et al.The Journal of Pathology|October 31, 2006
Genomic aberrations are rare in urothelial neoplasms of patients 19 years or youngerP J Wild, J Giedl, R Stoehr, et al.Pageof 16